R&D News | pharmaphorum

News

Sanofi and GSK begin clinical trials of coronavirus vaccine

Sanofi and GlaxoSmithKline have begun clinical trials of their coronavirus vaccine, as AstraZeneca expanded studies of its rival into Japan.

News

England trials population testing for COVID-19

England is to trial population testing for COVID-19 in places such as schools, colleges and busy public spaces.

News

Fake Dictionary, Dictionary definition of the word Schizophrenia.

BioXcel's phase 3 schizophrenia film has blockbuster potenti...

A sublingual film for acute agitation in schizophrenia and bipolar disorder from BioXcel has blockbuster potential that could pose a threat to an inhaled rival from Galen, according to anal

News

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

Compass plans $100m IPO to fund magic mushroom depression dr...

UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic m

News

EU regulators begin fast review of dexamethasone for COVID-1...

European regulators have begun a speedy review of dexamethasone as a treatment for adults hospitalised with COVID-19, a potentially cheaper option to aid recovery than Gilead’s Veklury.

News